IBS

11 drugs in development·6 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
IBSRELA	ARDELYX, INC. (ARDX)
inFoods® (IBS)	BIOMERICA INC (BMRA)
LINZESS	IRONWOOD PHARMACEUTICALS INC (IRWD)
trulance	SYNERGY PHARMACEUTICALS LLC (SGYP)
Trulance	Bausch Health Companies Inc. (BHC)
Xifaxan	Bausch Health Companies Inc. (BHC)

Phase 3(2)

Drug	Company
tenapanor (CIC label extension / ACCEL (ten-03-301))	ARDELYX, INC. (ARDX)
tenapanor 25 mg bid	ARDELYX, INC. (ARDX)

Phase 2(1)

Drug	Company
tenapanor	ARDELYX, INC. (ARDX)

Preclinical(1)

Drug	Company
prana bio nutrient medicinals	UNITED CANNABIS CORP (CNAB)

Unknown(1)

Drug	Company
inFoods® IBS	BIOMERICA INC (BMRA)

BioSniper tracks 11 drugs in development for IBS across 6 companies.

There are 1 clinical trial targeting IBS tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.